Orencia 250 MG vials
Ended Awarded
- Contract number
- SPE2DB26FWVQW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $129,724
Award facts
- Contract value 100% obligated
- $129,724.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $129,724.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Orencia 250 mg vials. This is a competitively awarded contract with no set-aside designation, with an ultimate completion date of October 29, 2025. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. The company's federal contract awards with the DLA demonstrate its capability to fulfill diverse pharmaceutical needs across multiple therapeutic domains. Orencia (abatacept) is a biologic immunosuppressant used to treat rheumatoid arthritis and other autoimmune conditions, reflecting the company's role in providing specialized pharmaceutical support to the military healthcare system and other federal health agencies including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DB26FWVQW?
SPE2DB26FWVQW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FWVQW worth?
The government has obligated $129,724 on SPE2DB26FWVQW.
Is contract SPE2DB26FWVQW an order under another contract?
Yes. SPE2DB26FWVQW is a delivery order under SPE2DB25D3012, an indefinite delivery contract.
Was contract SPE2DB26FWVQW competed?
The extent of competition for SPE2DB26FWVQW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award